Xconomy

MAY 9, 2019

According to IPO research firm Renaissance Capital , 47 IPOs have priced so far this year across all sectors, down 27 percent compared to the same period in 2018. To date in 2019, 23 healthcare-related companies have gone public, the most of any sector. Five biotechs priced their IPOs and at least one more is coming. Here’s a look.

Pricing

Startup Professionals Musings

NOVEMBER 28, 2020

The rate of new entrepreneurs increased between 2013 and 2019, from 280 out of 100,000 to 310 out of 100,000 of the adult population. Before you bring on partners, develop intellectual property, raise capital, or generate revenues, you need to establish an official business entity. Establishing your brand with interactive social media.

Tips

Both Sides of the Table

JANUARY 10, 2021

I mostly talk about startups, technology & venture capital. Peloton lifted my mental spirits in 2019/2020 through what were two emotionally draining years in the world (fires, protests, politics, he who shall not be named, etc). Mental Psyche [If you want to sign-up for my free newsletter you can click here. It was inspiring.

Coach

Xconomy

DECEMBER 21, 2018

Before you fly off, or drive, or simply unplug, check out our preview of what could be next year’s top clinical studies; the tumult in big pharma’s on again-off again relationship with consumer healthcare; big names on the move in the nation’s capital; and a flurry of year-end deals. Happy holidays, everyone.

Pricing

Xconomy

OCTOBER 23, 2018

Ed Kaye stepped aside from Sarepta Therapeutics (NASDAQ: SRPT ) last year after leading the company through one of the most noteworthy and controversial drug approvals in recent memory, for the Duchenne muscular dystrophy drug eteplirsen (Exondys 51). But his hiatus from a publicly traded biotech could be short-lived.

Funding

Xconomy

DECEMBER 3, 2018

The acquisition, which is expected to close by the end of March 2019, continues San Diego-based ResMed’s (NYSE: RMD ) “connected healthcare” push that began about five years ago, as Xconomy chronicled last year.

San Diego

Xconomy

JANUARY 2, 2019

So, you might imagine that his outlook on data protection for 2019 would be more optimistic than in past years, because businesses now take advantage of a broad choice of security services to protect themselves. Bob Ackerman is one of the venture capitalists whose funding has long fed the growth of the burgeoning cybersecurity industry.

Venture Capital

socalTECH

DECEMBER 26, 2018

Are there any technology innovations, gadgets, devices, software, that you found most interesting in 2018? Though both VR and Amazon Alexa arent new anymore, I was excited to see that both are becoming mainstream - moving beyond novelty to a number of high value applications.

Southern California

Startup Professionals Musings

SEPTEMBER 4, 2019

These days, by starting a blog or publishing on the Internet, you don’t have to be a social butterfly to get supporters and be recognized as an influencer. Capitalize on your strengths, and forget weaknesses. Marty Zwilling First published on Inc.com on 08/20/2019. Increase your visibility and expertise in your domain.

Entrepreneur

Xconomy

DECEMBER 15, 2018

It’s next week or never (until 2019, that is) for two San Diego companies that have filed documents with securities regulators indicating plans to go public. Will “CBUS” and “SI” join “THOR” and “RMED”?

San Diego

Startup Professionals Musings

JULY 7, 2019

Assess your intellectual capital and how to increase it. More intellectual capital means that you are worth more today in the marketplace. Take advantage of any and all current opportunities, such as industry conferences and special projects, to increase your intellectual capital for current roles and gigs in the future.

Artificial Inteligence

Startup Professionals Musings

APRIL 24, 2019

You too can become an influencer through social media, videos and blogs, and people will follow you on what to buy, what causes to support, and who to vote for. Marty Zwilling First published on Inc.com on 04/10/2019. Consider Jeff Bezos at the top of Amazon, or Howard Schultz at the top of Starbucks.

Customer

Xconomy

APRIL 27, 2020

In March 2019 it extended the Series A, tacking on $22 million more. On Monday Erasca—a portmanteau of “erase” and “cancer”— announced it had completed a Series B financing round jointly led by Arch Venture Partners and Cormorant Asset Management. Read more » Reprints | Share:

San Diego

Xconomy

JANUARY 10, 2019

The market caps of some of the most successful tech titans reach as high as $1 trillion. Yet in 2018, perceptions about these dominant companies often reflected uneasiness and doubt—and for some, so did their stock performance.

Platform

Startup Professionals Musings

APRIL 19, 2019

Test interest in a new product, before you spend money building it, by presenting it to the market in a blog or through crowd funding. Use these principles to capitalize on “failing more” as “trying more.” Marty Zwilling First published on Inc.com on 04/04/2019. If you see no interest, you can fail quickly at very low cost.

Guide

Xconomy

JANUARY 24, 2019

But looking back from the viewpoint of 2019, it’s worth considering whether the really pivotal, world-changing advances in transportation have not already been launched. It came in relatively quick steps: —The first time a person with a smartphone stepped into a car, that vehicle became, by proxy, a connected device with GPS.

Mobile

Xconomy

JULY 17, 2020

In the second quarter, 16 of the top 25 largest early-stage venture capital deals were investments in life science companies. The figures come from the National Venture Capital Association and financial research firm Pitchbook.

Venture Capital

TechCrunch LA

NOVEMBER 4, 2019

First it was street-style photography, then came the launch of her popular fashion blog WeWoreWhat. Bain Capital Ventures' Jamison Hill. CEO of Patreon Jack Conte attends VidCon 2019 at Anaheim Convention Center on July 12, 2019 in Anaheim, California (Photo by Jerod Harris/Getty Images).

Platform

TechCrunch LA

OCTOBER 26, 2021

One recent example of this phenomenon is Tamsyn Muir’s “Gideon the Ninth,” published in 2019, which the New York Times called “a devastating debut that deserves every ounce of hype it’s received.” But Muir isn’t secretive that she got her start writing fan fiction. This mistrust goes back years to the founding of Archive of Our Own.

Writing

Xconomy

JANUARY 4, 2019

What will make our Best of 2019 list? Topics ranged from the worries over CRISPR genome editing and Wild West biohacking, to Nobel Prize-fueled drug approvals and the headaches around drug prices (even for drugs meant to cure headaches). Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing

Xconomy

JANUARY 15, 2019

As Xconomy’s editors looked back at the year just passed, we asked technology leaders to comment on the trends they’d observed in 2018, and the developments they expected in 2019.

.Net

Xconomy

FEBRUARY 16, 2018

Amid it all, we tried to parse what the Trump administration’s 2019 budget proposal meant for the biomedical and life-science worlds. Another week of White House chaos and American gun violence.

Pricing